Andreessen Horowitz (a16z) has made its first investment in a decentralized science (DeSci) project, backing AminoChain with $5M in a seed funding round.
In 1951, Henrietta Lacks' cells were taken without her knowledge or consent. Her cells, known now as “HeLa” cells, went on to become one of the most important tools in modern medicine, leading to breakthroughs in healthcare from the polio vaccine to cancer treatments. For 72… pic.twitter.com/01tZme6gLL
— AriannaSimpson.eth (@AriannaSimpson) September 25, 2024
The funding, led by a16z, will support AminoChain’s development of a decentralized biobank and Layer 2 network. The project aims to improve ownership, transparency, and consent in medical data collection, utilizing blockchain technology to allow enterprise medical institutions to share data securely and while maintaining patient privacy.
cryptobriefing.com